Lymphedema Awareness Week 2026

March 2–8, 2026 | World Lymphedema Day – March 6

 

Every March, healthcare organizations worldwide observe Lymphedema Awareness Month, with Lymphedema Awareness Week taking place March 2–8, 2026, and World Lymphedema Day recognized on March 6.

These dates aim to increase understanding of lymphedema — a chronic lymphatic disease affecting an estimated 250 million people globally — and to address ongoing gaps in diagnosis and long-term management.

Understanding Lymphedema

Lymphedema is a chronic condition characterized by persistent swelling due to impaired lymphatic system function. When lymphatic vessels cannot adequately transport lymph fluid, fluid accumulates in the surrounding tissues.

It most commonly affects the arms and legs but may also involve the trunk, head, neck, or genital region

Two primary forms are recognized:

Primary Lymphedema

A rare, genetic or developmental abnormality of the lymphatic system.

Secondary Lymphedema

The more common form, often associated with:

• Cancer surgery or radiation therapy

• Lymph node removal

• Trauma or infection

• Chronic venous disease

Research indicates that up to 30% of breast cancer survivors may develop secondary lymphedema, sometimes years after treatment.

Why Lymphedema Awareness Week Is Clinically Important

 

Lymphedema is frequently underdiagnosed in its early stages. Swelling may initially be subtle and mistaken for temporary edema or weight-related changes.

Delayed recognition increases the risk of:

• Tissue fibrosis

• Recurrent cellulitis

• Skin complications

• Functional limitations

• Reduced quality of life

Evidence consistently shows that earlier identification and structured intervention improve long-term management outcomes.

Lymphedema Awareness Week promotes:

• Greater awareness of early symptoms

• Timely referral to trained clinicians

• Standardized treatment protocols

• Ongoing professional education and research

Evidence-Based Lymphedema Treatment

Although lymphedema has no cure, comprehensive management significantly reduces progression and complications.

Current evidence-based treatment approaches include:

• Manual lymphatic drainage

• Medical compression garments

• Therapeutic exercise

• Skin integrity management

• Intermittent Pneumatic Compression (IPC) integrated within multidisciplinary care plans

IPC systems are incorporated in many clinical settings to support lymphatic fluid mobilization as part of structured therapy.

Successful long-term management depends on consistency, individualized care planning, and patient adherence.

Global Recognition: 

• Lymphedema Awareness Month — March 2026
• Lymphedema Awareness Week — March 2–8, 2026
• World Lymphedema Day — March 6, 2026
• March was designated Lymphedema Awareness Month following initiatives led by the National Lymphedema Network (NLN) — 1998
• World Lymphedema Day was established through a global initiative led by the Lymphatic Education & Research Network (LE&RN) — March 6, 2016

These observances strengthen collaboration among clinicians, researchers, advocacy groups, and healthcare technology leaders focused on improving lymphatic disease management.

Lympha Press and Ongoing Commitment to Lymphatic Health

For decades, Lympha Press® has been dedicated to advancing Intermittent Pneumatic Compression technology within clinical and home-care environments. Developed and manufactured by Mego Afek, Lympha Press systems are designed to support structured lymphedema management programs under medical supervision.

During Lymphedema Awareness Week and throughout the year, our focus remains on supporting healthcare professionals with evidence-based compression solutions that contribute to improved long-term patient outcomes.